3billion (394800.KQ) — Stock Score Summary

3billion (394800.KQ) has a MoatMap StockRank of 12/100 based on Quality (35/100), Value (36/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL.

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment.

Key Financial Metrics

Price$4.85
Market Cap$154M
P/E (Forward)39.67
Price/Book9.91
Return on Equity-20.9%
Return on Invested Capital-19.8%
Debt/Equity14.24
Gross Margin-50.3%
Operating Margin-27.3%
Revenue Growth98.3%
Free Cash Flow$-808.92

3billion operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is 3billion’s (394800.KQ) StockRank?
MoatMap’s StockRank for 3billion (394800.KQ) is 12/100, with a Strong Sell signal. It is a composite of Quality (35), Value (36), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does 3billion have an economic moat?
3billion (394800.KQ) has a Quality factor score of 35/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is 3billion a buy, hold, or sell?
MoatMap’s current signal for 3billion (394800.KQ) is Strong Sell, based on a StockRank of 12/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is 3billion in?
3billion (394800.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).